AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke

Author(s): Clarkson AN, Overman JJ, Zhong S, Mueller R, Lynch G, et al.

Abstract

Stroke is the leading cause of adult disability. Recovery after stroke shares similar molecular and cellular properties with learning and memory. A main component of learning-induced plasticity involves signaling through AMPA receptors (AMPARs). We systematically tested the role of AMPAR function in motor recovery in a mouse model of focal stroke. AMPAR function controls functional recovery beginning 5 d after the stroke. Positive allosteric modulators of AMPARs enhance recovery of limb control when administered after a delay from the stroke. Conversely, AMPAR antagonists impair motor recovery. The contributions of AMPARs to recovery are mediated by release of brain-derived neurotrophic factor (BDNF) in periinfarct cortex, as blocking local BDNF function in periinfarct cortex blocks AMPAR-mediated recovery and prevents the normal pattern of motor recovery. In contrast to a delayed AMPAR role in motor recovery, early administration of AMPAR agonists after stroke increases stroke damage. These findings indicate that the role of glutamate signaling through the AMPAR changes over time in stroke: early potentiation of AMPAR signaling worsens stroke damage, whereas later potentiation of the same signaling system improves functional recovery.

Similar Articles

Induction of vertebrate regeneration by a transient sodium current

Author(s): Tseng AS, Beane WS, Lemire JM, Masi A, Levin M

Plasticity in the intrinsic excitability of cortical pyramidal neurons

Author(s): Desai NS, Rutherford LC, Turrigiano GG

The role of injury discharge in the induction of neuropathic pain behavior in rats

Author(s): Seltzer Z, Beilin BZ, Ginzburg R, Paran Y, Shimko T

ATP release from dorsal spinal cord synaptosomes: characterization and neuronal origin

Author(s): Sawynok J, Downie JW, Reid AR, Cahill CM, White TD

Spinal cord injury immediately decreases anesthetic requirements in rats

Author(s): Foffani G, Humanes-Valera D, Calderon-Muñoz F, Oliviero A, Aguilar J

The effect of glutamate receptor blockers on glutamate release following spinal cord injury

Author(s): McAdoo DJ, Hughes MG, Nie L, Shah B, Clifton C, et al.

Pulmonary vasodilation by ketamine is mediated in part by L-type calcium channels

Author(s): Kaye AD, Banister RE, Anwar M, Feng CJ, Kadowitz PJ, et al.

Neuroprotective effects of riluzole and ketamine during transient spinal cord ischemia in the rabbit

Author(s): Lips J, de Haan P, Bodewits P, Vanicky I, Dzoljic M, et al.

The involvement of the mu-opioid receptor in ketamine-induced respiratory depression and antinociception

Author(s): Sarton E, Teppema LJ, Olievier C, Nieuwenhuijs D, Matthes HW, et al.

Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

Author(s): Nemeth CL, Paine TA, Rittiner JE, Béguin C, Carroll FI, et al.

Calcium-dependent glutamate release concomitant with massive potassium flux during cerebral ischemia in vivo

Author(s): Katayama Y, Kawamata T, Tamura T, Hovda DA, Becker DP, et al.

Regional distribution and postnatal changes of D-amino acids in rat brain

Author(s): Hamase K, Homma H, Takigawa Y, Fukushima T, Santa T, et al.

Characterization of electrically evoked [3H]-D-aspartate release from hippocampal slices

Author(s): Savage DD, Galindo R, Queen SA, Paxton LL, Allan AM

Spinal cord injury causes a wide-spread, persistent loss of Kir4

Author(s): Olsen ML, Campbell SC, McFerrin MB, Floyd CL, Sontheimer H

Long-term potentiation and contextual fear conditioning increase neuronal glutamate uptake

Author(s): Levenson J, Weeber E, Selcher JC, Kategaya LS, Sweatt JD, et al.

Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation

Author(s): Correia SS, Bassani S, Brown TC, Lisé MF, Backos DS, et al.

Differential trafficking of AMPA and NMDA receptors during long-term potentiation in awake adult animals

Author(s): Williams JM, Guévremont D, Mason-Parker SE, Luxmanan C, Tate WP, et al.

Effect of intravenous lidocaine on experimental spinal cord injury

Author(s): Kobrine AI, Evans DE, LeGrys DC, Yaffe LJ, Bradley ME

Effect of lidocaine treatment on acute spinal cord injury

Author(s): Haghighi SS, Chehrazi BB, Higgins RS, Remington WJ, Wagner FC

Protection against experimental ischemic spinal cord injury

Author(s): Robertson CS, Foltz R, Grossman RG, Goodman JC